Glenmark gets regulator’s approval to try Favipiravir on COVID-19 patients in India
MUMBAI: Glenmark Pharmaceuticals, a research-led pharmaceutical company, announced that it has received approval from the DCGI (Drug Controller General of India), the regulator in India to conduct clinical trials on Favipiravir Antiviral tablets on COVID-19 patients. The product is a…